Our focus has, is and always will be to ensure safe food for families who rely on us for our high-quality nutrition products.
Abbott takes employee concerns very seriously and we foster a culture of compliance to produce the best and highest-quality formula. We empower our employees to identify and report any issues that could compromise our product safety or quality, which comes before any other considerations.
With regard to the document released by Congresswoman Rosa DeLauro (D-Conn.) this former employee was dismissed due to serious violations of Abbott’s food safety policies. After dismissal, the former employee, through their attorney, has made evolving, new and escalating allegations to multiple authorities.
Abbott is reviewing this new document and will thoroughly investigate any new allegations.
After a thorough investigation at the Sturgis, Mich., facility by the Food and Drug Administration (FDA) and Abbott, there are a number of important findings. Abbott tests products prior to distribution, and no Abbott formula distributed to consumers tested positive for Cronobacter sakazakii or Salmonella. Testing of retained products by Abbott and FDA for Cronobacter sakazakii and/or Salmonella all came back negative. No Salmonella was found at the Sturgis facility during the investigation. The Cronobacter sakazakii that was found in environmental testing during the investigation was in non-product contact areas of our Sturgis facility and has not been linked to the two available patient samples or any other known infant illness.
A thorough review of all available data indicates that the infant formula produced at our Sturgis facility is not likely the source of infection in the reported cases and that there was not an outbreak caused by products from the facility.
We know this recall exacerbated the industry-wide infant formula shortage and we’re doing everything we can to increase supply from other plants as we continue to work closely with the FDA to resolve this matter.